CAD 4.87
(-1.22%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 1.19 Billion | 1.5 Billion | 1.01 Billion | 464.64 Million | 836.93 Million | 809.63 Million |
Cost of Revenue | 900.27 Million | 773.65 Million | 451.74 Million | 304.76 Million | 417.82 Million | 594.33 Million |
Gross Profit | 294.8 Million | 731.03 Million | 564.58 Million | 159.88 Million | 419.1 Million | 215.3 Million |
Operating Expenses | 592.84 Million | 447.49 Million | 256.61 Million | 339.43 Million | 313.63 Million | 281.61 Million |
Selling, General and Administrative Expenses | 169.83 Million | 146.64 Million | 126.95 Million | 106.08 Million | 130.55 Million | 122.61 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 300.85 Million | 129.66 Million | 233.35 Million | 183.07 Million | 29.03 Million |
Cost and Expenses | 856.56 Million | 1.22 Billion | 708.35 Million | 644.19 Million | 731.46 Million | 875.95 Million |
Operating Income | -180.76 Million | 286.76 Million | 307.29 Million | -187.28 Million | 104.23 Million | -66.31 Million |
Interest Expense | 30.39 Million | 78.98 Million | 77.16 Million | 63.18 Million | 62.84 Million | 60.24 Million |
Income Tax Expense | 14.08 Million | -413.28 Million | 77.16 Million | 63.18 Million | 62.84 Million | -443.1 Million |
Earnings before Tax | -37.13 Million | 158.98 Million | 457.6 Million | -657.52 Million | 246.86 Million | -569.65 Million |
Net Income | -51.22 Million | 572.27 Million | 457.6 Million | -720.71 Million | 184.02 Million | -569.65 Million |
Earnings Per Share Basic | -0.09 | 1.01 | 0.86 | -1.36 | 0.35 | -1.11 |
Earnings Per Share Diluted | -0.09 | 0.98 | 0.84 | -1.36 | 0.35 | -1.11 |
Weighted Average Shares Outstanding | 583.75 Million | 568.03 Million | 530.69 Million | 528.83 Million | 521.31 Million | 513.2 Million |
Weighted Average Shares Outstanding (Diluted) | 583.75 Million | 586.91 Million | 546.71 Million | 528.83 Million | 526.29 Million | 514.15 Million |
Gross Margin | 0.25 | 0.49 | 0.56 | 0.34 | 0.50 | 0.27 |
EBIT Margin | 0.09 | 0.27 | 0.40 | -0.16 | 0.28 | 0.11 |
Profit Margin | -0.04 | 0.38 | 0.45 | -1.55 | 0.22 | -0.70 |
EBITDA | 111.83 Million | 370.67 Million | 649.06 Million | -457.95 Million | 463.55 Million | -327.47 Million |
Earnings Before Tax Margin | -0.15 | 0.19 | 0.30 | -0.40 | 0.12 | -0.08 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 352.02 Million | 369.41 Million | 297.26 Million | 1.19 Billion | 298.05 Million | 379.24 Million |
Cost of Revenue | 206.73 Million | 221.75 Million | 218.41 Million | 900.27 Million | 228.56 Million | 171.14 Million |
Gross Profit | 145.28 Million | 147.66 Million | 78.85 Million | 294.8 Million | 69.48 Million | 208.09 Million |
Operating Expenses | 6.84 Million | 11.34 Million | 19.92 Million | 74.87 Million | 8.04 Million | 122.72 Million |
Selling, General and Administrative Expenses | 6.84 Million | 11.34 Million | 19.92 Million | - | 8.04 Million | 43.99 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 11.34 Million | - | - | - | - |
Cost and Expenses | 213.57 Million | 233.1 Million | 238.33 Million | 975.14 Million | 236.61 Million | 293.87 Million |
Operating Income | 138.44 Million | 136.31 Million | 58.93 Million | 219.93 Million | 61.43 Million | 87.49 Million |
Interest Expense | 18.81 Million | 8.6 Million | 8.38 Million | 30.39 Million | 8.12 Million | 9.93 Million |
Income Tax Expense | 21.51 Million | 30.56 Million | 13.04 Million | 14.08 Million | 28.3 Million | -16.5 Million |
Earnings before Tax | 91.8 Million | 128.63 Million | 51.54 Million | -37.13 Million | 55.8 Million | -95.71 Million |
Net Income | 68.72 Million | 96.07 Million | 38.5 Million | -51.22 Million | 27.5 Million | -79.21 Million |
Earnings Per Share Basic | 0.13 | 0.17 | 0.07 | - | 0.05 | -0.14 |
Earnings Per Share Diluted | 0.12 | 0.17 | 0.07 | - | 0.05 | -0.14 |
Weighted Average Shares Outstanding | 540.88 Million | 557.29 Million | 567.07 Million | 583.75 Million | 574.41 Million | 581.91 Million |
Weighted Average Shares Outstanding (Diluted) | 550.71 Million | 566.55 Million | 577.1 Million | 583.75 Million | 588.49 Million | 581.91 Million |
Gross Margin | 0.41 | 0.40 | 0.27 | 0.25 | 0.23 | 0.55 |
EBIT Margin | 0.41 | 0.45 | 0.28 | - | 0.29 | 0.31 |
Profit Margin | 0.20 | 0.26 | 0.13 | -0.04 | 0.09 | -0.21 |
EBITDA | 144.21 Million | 167.89 Million | 84.59 Million | - | 87.82 Million | 116.13 Million |
Earnings Before Tax Margin | 0.39 | 0.37 | 0.20 | 0.18 | 0.21 | 0.23 |
8160
3539
GAGAN
EXCELINDUS
AARTIPHARM
ALB